Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest Chinese Healthcare Reform Release Offers Little Change

This article was originally published in PharmAsia News

Executive Summary

According to an industry insider privy to China's healthcare reform draft soliciting the latest round of public opinion (PharmAsia News, Sep.15, 2008), the overall plan does not differ much from the previous version in terms of new concepts or changes. It seems to hammer together hodge-podge proposals from various organizations, with little specifics on execution and operation. Although the reform seeks to resolve the problem of "medical care sustained by drug income" through separate management of hospitals' income and expenses, the strategy does not address the fundamental issues. Current media only cover small portions of the entire plan as the opinion soliciting period will only be closed in about a month's time. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069692

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel